Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
Tickers BIIB ESALF ESALY
Tags Biotech ESALF General
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags General ATNX BIIB
From Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
Tickers BIIB CEMI ESALY EYEN
Tags EYEN IBB MRK
From Benzinga
Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting
Tickers ESALF ESALY MRK
Tags Health Care Benzinga General
From Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
Tickers ALKS AMGN ARGX BGNE
Tags ALKS General Benzinga
From Benzinga
Merck Snags Yet Another Indication for This Drug Combo
Tickers ESALY MRK
Tags Market News MRK ESALY
From Motley Fool
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
Tickers BIIB ESALF ESALY LLY
Tags Trading Ideas Alzheimer's disease News
From Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
Tickers BIIB ESALF ESALY
Tags FDA Biotech ESALF
From Benzinga
Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma
Tickers ESALF ESALY MRK
Tags Biotech MRK Market News
From Benzinga
Why Are Biogen Shares Gaining Today?
Tickers BIIB ESALF ESALY
Tags ESALF Phase 3 Trial Biotech
From Benzinga
Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
Tickers BIIB ESALF ESALY
Tags Market News Briefs ESALY
From Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
Tickers APTO APYX BIIB BLFS
Tags TXMD APYX APTO
From Benzinga
3 Big Problems With Biogen's Q3 Results
Tickers BIIB ESALY SAGE
Tags SAGE BIIB ESALY
From Motley Fool
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Market News ESALY Briefs
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Tickers AFIB ALT AMZN APYX
Tags ORMP CYTK PASG
From Benzinga
How Keytruda's Latest Approval in China Boosts Merck
Tickers ESALY MRK
Tags MRK Market News ESALY
From Motley Fool
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential
Tickers CTXR ESALY RDY
Tags Benzinga Analyst Ratings General
From Benzinga
Merck Investors Have Reason to Cheer This Label Expansion
Tickers ESALY MRK
Tags ESALY Market News MRK
From Motley Fool
Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma
Tickers ESALF ESALY RDY
Tags Market News Asset Sales oncology
From Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Tickers ABSI AGEN ALKS AXNX
Tags ELYM INAB REGN
From Benzinga
Amid Medicare Uncertainty, Biogen Offers Its Alzheimer's Drug For Free
Tickers BIIB ESALF ESALY
Tags Biotech ESALF General
From Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
Tickers ADGI ASND BNR BNTX
Tags BTCY CNTB ADGI
From Benzinga
What This Label Expansion Means for Merck
Tickers ESALY MRK PFE
Tags MRK PFE Market News
From Motley Fool
White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg
Tickers BIIB ESALF ESALY
Tags Biotech Government ESALF
From Benzinga
Controversial Aduhelm To Administered At More Than 300 Hospitals: Nikkei's
Tickers BIIB ESALF ESALY
Tags BIIB Health Care Benzinga
From Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Tickers ABSI AXSM BIOC BNTX
Tags MLSS Benzinga MRNA
From Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Tickers ABCL ACET ACHV ADGI
Tags ACET VIVE CLRB
From Benzinga
Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs
Tickers BIIB ESALF ESALY
Tags Health Care News Alzheimer's disease
From Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
Tickers ALBO AXSM CARA CCXI
Tags News PFE ITRM
From Benzinga
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Tickers ABBV ABSI ACET ALKS
Tags News INVA LXRX
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.